A unique range of integrated early stage development services to support biopharmaceutical drug development.
Part of Sartorius Stedim Biotech since 2015, BioOutsource and Cellca bring together a unique range of outsourced services to support the early stage development of biopharmaceutical drugs:
Cell Line Development
Upstream Process Development
Cell Bank Manufacturing
Cell Bank Characterisation
GMP Lot Release
Solutions through experience
This extensive suite of services combines Cellca's cell line and upstream process development expertise with BioOutsource's bioanalytical and biosafety contract testing expertise to support customers from cell line development, through product manufacture and release. Broadening Sartorius Stedim Biotech's portfolio of products, technologies and services and enabling a comprehensive "Total Solution" to support our clients' drug development activities.
Benefit from the combined experience of Cellca, BioOutsource and Sartorius Stedim Biotech to efficiently advance your drug candidates quickly from early stage development through to commercialisation.
Accelerated drug development
Based on its unparalleled global experience working to support biological drug development, BioOutsource and Cellca lead the way in preclinical development. Through our robust platforms, off-the-shelf assays and commitment to providing a total solution, Sartorius Stedim Biotech can accelerate your drug's development.
BioOutsource and Cellca have industry leading expertise in supporting biosimilar drug development. Collectively we have worked with over 50 biosimilar developers across 12 countries, totalling 230 biosimilar projects. Benefit from our combined experience and integrated services to further mitigate risks and select optimal biosimilar clones. Find out more.
Our service offering is underpinned by our commitment to delivering excellent customer service, navigating our customers through the complexities of the drug development cycle and enabling them to make informed data-driven decisions. Our client management team provide an intimate customer experience and ensure your project is managed efficiently and delivered on time. Effective communication is key to success, and our team understand that a transparent, proactive approach to customer service will ensure the delivery of a truly differentiated solution.
Contact our experts today to discuss your drug development programmes.
In-depth profiling of IgG glycosylation coupled with ADCC assays enables generation of robust biosimilar comparability data Glasgow, UK – July 7, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launched of a new Released N-Glycan Assay for the in-depth profiling of IgG glycosylation. This new physico-chemical assay, More
To help Indian researchers access a portfolio of excellent services from BioOutsource and Cellca Glasgow, UK – June 29, 2016: Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, is pleased to announce that its subsidiary BioOutsource has appointed Ravin Mehta as Technical Sales Specialist to enable customers to have access to More
Cellca’s Cell Line and Upstream Process Development Services Now Integrated Glasgow, UK – June 14, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced that its subsidiary BioOutsource launched an updated website to spotlight Sartorius Stedim Cellca’s cell line and upstream process development services for the biopharmaceutical industry. The new More